Who
John W. Shiver
Director
Company insider
Files Form 4 as: Director, Novavax; Director and Other, Icosavax.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 3 Jan 2022
- Last trade
- 18 Jun 2026
- Last filed
- 23 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 23 Jun 2026 | NVAX Novavaxoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,270 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | NVAX Novavaxoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,180 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | NVAX Novavaxoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,270 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | NVAX Novavaxoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,180 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | NVAX NovavaxBiotechnology | SEC FORM 4 Code M | —7,947 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | NVAX Novavaxoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,947 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | NVAX Novavaxoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,947 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | NVAX NovavaxBiotechnology | SEC FORM 4 Code M | —7,947 at $0.00 | filing |
| 10 Mar 2025filed 12 Mar 2025 | NVAX Novavaxoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,770 at $0.00 | filing |
| 10 Mar 2025filed 12 Mar 2025 | NVAX Novavaxoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,840 at $0.00 | filing |
| 19 Feb 2024filed 20 Feb 2024 | Icosavaxoption or derivative | SEC FORM 4 Code D | —9,643 | filing |
| 19 Feb 2024filed 20 Feb 2024 | Icosavaxoption or derivative | SEC FORM 4 Code D | —17,000 | filing |
| 19 Feb 2024filed 20 Feb 2024 | Icosavaxoption or derivative | SEC FORM 4 Code D | —25,500 | filing |
| 19 Feb 2024filed 20 Feb 2024 | Icosavax | SEC FORM 4 Code U | —8,066 | filing |
| 19 Feb 2024filed 20 Feb 2024 | Icosavax | SEC FORM 4 Code D | —2,833 | filing |
| 6 Jun 2023filed 8 Jun 2023 | Icosavaxoption or derivative | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 10 Jun 2022filed 14 Jun 2022 | Icosavaxoption or derivative | SEC FORM 4 Code A | —9,643 at $0.00 | filing |
| 10 Jun 2022filed 14 Jun 2022 | Icosavax | SEC FORM 4 Code A | —2,399 at $0.00 | filing |
| 3 Jan 2022filed 5 Jan 2022 | Icosavaxoption or derivative | SEC FORM 4 Code A | —25,500 at $0.00 | filing |
| 3 Jan 2022filed 5 Jan 2022 | Icosavax | SEC FORM 4 Code A | —8,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.